Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aptevo Therapeutics (APVO) EBT Margin (2016 - 2022)

Historic EBT Margin for Aptevo Therapeutics (APVO) over the last 8 years, with Q1 2022 value amounting to 180.19%.

  • Aptevo Therapeutics' EBT Margin rose 1043200.0% to 180.19% in Q1 2022 from the same period last year, while for Dec 2022 it was 919.75%, marking a year-over-year decrease of 7456500.0%. This contributed to the annual value of 919.75% for FY2022, which is 7456500.0% down from last year.
  • According to the latest figures from Q1 2022, Aptevo Therapeutics' EBT Margin is 180.19%, which was up 1043200.0% from 110.23% recorded in Q4 2021.
  • Aptevo Therapeutics' EBT Margin's 5-year high stood at 105.97% during Q4 2019, with a 5-year trough of 1439.11% in Q2 2020.
  • In the last 5 years, Aptevo Therapeutics' EBT Margin had a median value of 183.99% in 2021 and averaged 296.13%.
  • Per our database at Business Quant, Aptevo Therapeutics' EBT Margin crashed by -12638900bps in 2020 and then soared by 12551200bps in 2021.
  • Aptevo Therapeutics' EBT Margin (Quarter) stood at 215.69% in 2018, then surged by 51bps to 105.97% in 2019, then plummeted by -171bps to 287.36% in 2020, then surged by 62bps to 110.23% in 2021, then crashed by -63bps to 180.19% in 2022.
  • Its last three reported values are 180.19% in Q1 2022, 110.23% for Q4 2021, and 153.42% during Q3 2021.